期刊文献+

等位基因HLA-A*02:09与4种HLA单倍体的关系及应用 被引量:1

The relationship and application between Allele HLA-A*02:09 and 4 haplotypes
下载PDF
导出
摘要 目的观察等位基因HLA-A*02:09与4种单倍体的关系,以通过筛检相关单倍体缩小模棱两可确认实验的检测范围。方法采用PCR-SSO-Luminex方法检测的HLA-A*02:01和A*02:09的模棱两可样本通过EX-ON4-7补充实验确认HIA-A*02:09阳性样本,并观察是否携带特定单倍体。结果对205例A*02:01/02:09的模棱两可样本进行了确认实验,包含携带4种单倍体的样本58例,3例检出A*02:09;未携带4种单倍体的147例未检出A*02:09。结论 HLA-A*02:01/02:09模棱两可的比例较高,筛检高危单倍体可有效缩小骨髓库入库样本发生A*02:01/02:09这一组模棱两可时的确认实验的检测范围。 Objective To investigate the degree of correlation between the HLA-allele A * 02 : 09 and 4 haplo- types and try to decrease confirmation tests of the ambiguous HLA-alleJe A * 02 : 01 and A * 02 : 09 by screening high risk haplotypes. Methods 1374 random samples from stem cell donors were analyzed using PCR-SSO-luminex and the unidentified samples were confirmed with confirmation test. Results 205 ambiguous HLA-A* 02 : 01 and A* 02:09 were tested in 1 374 samples. 58 of them had 4 haplotypes and 3 were identified as A * 02 : 09, while other 147 samples lacked A* 02 : 09. Conclusion There was high frequency of ambiguous HLA allele A* 02 :01 and A* 02 :09. Screening high risk haplotypes can effectively decrease the confirmation test of HLA-A * 02 : 01 and A * 02 : 09 ambiguities.
出处 《国外医学(医学地理分册)》 CAS 2012年第2期106-108,共3页 Foreign Medical Sciences:Section of Medgeography
关键词 HLA_A*02:09 模棱两可 单倍体 HLA-A * 02 :09 ambiguous typing haplotype
  • 相关文献

参考文献10

二级参考文献69

共引文献67

同被引文献11

  • 1HUH J,MUN Y C, SEONG C M, et al. Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t (14;20) in AML [J]. Cancer Genet, 2011,204(12) : 682-- 686.
  • 2DOUET-GUILBERT N,DE BRAEKELEER E,BASINKO A, et al. Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients [ J ]. Leukemia, 2012,26(7 ): 1 695-- 1 697.
  • 3KLUG C A. GM-CSFRalpha: the sex-chromosome link to t(8;21) (+) AML[J]. Blood,2012,119 (13):2 976 --2 977.
  • 4BEACH D F, BARNOSKI B L, AVIV H, et al. Duplication of chromosome 1 [dup (1) (q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML[J]. Cancer Genet,2012,205(12):665--668.
  • 5MACKINNON R N, CAMPBELL L J. Chromothripsis under the microscope: a cytogenetic perspective of two cases of AML with catastrophic chromosome rearrangement [J]. Cancer Genet, 2013,206(6):238--251.
  • 6DE FIGUEIREDO A F,MKRTCHYAN H,LIEHR T,et al. A case of childhood acute myeloid leukemia AML (M5) with a neocentric chromosome neo (1) (qter->q23 approximately 24::q23 approximately 24->q43-->,neo- ->q43-->qter) and tetrasomy of chromosomes 8 and 21 [ J ]. Cancer Genet Cytogenet, 2009,193 (2): 123 -- 126.
  • 7TREPPENDAHL M B,QIU X,SOGAARD A,et al. Allelie methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML[J]. Blood, 2012,119(1):206--216.
  • 8LI L J,TAO J L,FU R,et al. Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML [J]. Int J Hematol, 2014,100( 1 ) : 60--69.
  • 9TETTAMANTI S,BIONDI A,BIAGI E,et al. CD123 AML targeting by chimeric antigen receptors: A novel magic bul- let for AML therapeutics [ J ]. Oncoimmunology, 2014,3 ( 6 ): e28 835.
  • 10MOHSENI N S,REPP R,KELLNER C,et al. Enhanced ADCC activity of affinity maturated and Fc-engineered mi- ni-antibodies directed against the AML stem cell antigen CD96[J]. PLoS One,2012,7(8): e42 426.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部